SCHEMBL5764650

SCHEMBL5764650

COC(=O)c1cccc2ccc(-n3cnc4cc(OC)ccc43)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 3/20 0.49
FGFR1 P11362 7/20 0.49
SRC P12931 1/20 0.45
MAPT P10636 1/20 0.44
RAB9A P51151 1/20 0.44
HPGD P15428 3/20 0.43
TSHR P16473 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GAK O14976 1/20 0.42
RIPK2 O43353 1/20 0.42
ULK1 O75385 1/20 0.42
STK10 O94804 1/20 0.42
PRKD3 O94806 1/20 0.42
MAP4K4 O95819 1/20 0.42
LATS1 O95835 1/20 0.42
PAK4 O96013 1/20 0.42
NTRK1 P04629 1/20 0.42
LCK P06239 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5766520 0.90 FGFR1 (0.53) IRAK4FGFR1MAPTHPGDTSHR
SCHEMBL5766376 0.89 IRAK4 (0.42) IRAK4FGFR1SRCMAPTRAB9A
SCHEMBL5766774 0.86 IRAK4 (0.46) IRAK4FGFR1SRCMAPTRAB9A
SCHEMBL5768457 0.83 IRAK4 (0.48) IRAK4FGFR1MAPTRAB9AHPGD
SCHEMBL3838691 0.83 FGFR1 (0.54) IRAK4FGFR1MAPTHPGDTSHR
SCHEMBL5765710 0.81 FGFR1 (0.54) IRAK4FGFR1MAPTHPGDTSHR
SCHEMBL5764381 0.81 IRAK4 (0.44) IRAK4FGFR1SRCHPGDSMN1; SMN2
SCHEMBL5766594 0.77 FGFR1 (0.47) IRAK4FGFR1MAPTHPGDTSHR
SCHEMBL5764401 0.76 IRAK4 (0.47) IRAK4FGFR1MAPTRAB9AHPGD
SCHEMBL5765204 0.76 FGFR1 (0.46) IRAK4FGFR1MAPTHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019147-B1 Benzimidazole derivatives useful as antiproliferative agents PFIZER INC. (US) 2006-03-28 US claimed
EP-1235825-B1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS PFIZER PROD INC (US) 2006-01-25 EP claimed
EP-1235825-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS Pfizer Products Inc. (US) 2002-09-04 EP claimed
WO-2001040217-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS PFIZER PRODUCTS INC. (US) 2001-06-07 WO claimed
US-7019147-B1 Benzimidazole derivatives useful as antiproliferative agents PFIZER INC. (US) 2006-03-28 US disclosed
EP-1235825-B1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS PFIZER PROD INC (US) 2006-01-25 EP disclosed
EP-1235825-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS Pfizer Products Inc. (US) 2002-09-04 EP disclosed
WO-2001040217-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS PFIZER PRODUCTS INC. (US) 2001-06-07 WO disclosed